Merck To Acquire Pandion Therapeutics For $60 Per Share In Cash
February 25, 2021 at 08:45 AM EST
Merck and Pandion Therapeutics announced that the companies have entered into a definitive agreement, under which Merck, through a subsidiary, will acquire Pandion.
